The standard medication levodopa does not always work against tremors in Parkinson’s disease, especially in stressful situations.
Exscientia has backed the CDK7 candidate as the company “believes GTAEXS617 has the potential to overcome significant safety and efficacy limitations of existing approved treatments”.
Original-Research: MPH Health Care AG – from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company